Dolutegravir trials for HIV

All Dolutegravir trials · All HIV trials

Phase breakdown

Recruiting trials studying Dolutegravir for HIV

• Dolutegravir Pharmacokinetics During Weekly Rifapentine/Isoniazid for TB Prevention
  NCT06281834 · Phase: Phase 1 · Ages: 4 Weeks to 11 Years · Sex: All (male and female) · 1 location
• Doravirine Dose Optimisation in Pregnancy
  NCT05630638 · Phase: Phase 4 · Ages: 18 Years and older · Sex: Female · 1 location
• Early Metabolic Effects of Antiretroviral Drugs in Healthy volUnteers: a Phase 2 Randomized Study
  NCT05652478 · Phase: Phase 2 · Ages: 18 Years to 55 Years · Sex: All (male and female) · 1 location
• Efficacy of Doravirine + Dolutegravir Dual Therapy in the Context of Antiretroviral Therapy Switch
  NCT04892654 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 3 locations
• Multi Interventional Approaches to Mitigate HIV Reservoirs for the Sustained HIV Remission Without Antiretrovirals
  NCT06805656 · Phase: Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location

Common questions

How many trials study Dolutegravir for HIV?

5 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.